Safety alerts
28 safety alerts appeared in Germany during Week 16, 2026. Safety concentration usually matters to quality, vigilance, and post-market surveillance teams because it can reveal emerging field risks.
Signals from 2026-04-13 to 2026-04-19, covering safety alerts, regulatory changes, device registrations, market movement, and source activity for Germany.
Germany generated 29 qualifying medical device signals during Week 16, 2026. Safety alerts led the week with 28 signals, while FDA Device Enforcement was the most active source. LAI-PrEP testing strategies show similar HIV detection rates but RDTs offer faster results and lower costs. Philips recalls ALLURA Xper FD20 OR Table due to intermittent X-ray imaging issues with the foot switch.
28 safety alerts appeared in Germany during Week 16, 2026. Safety concentration usually matters to quality, vigilance, and post-market surveillance teams because it can reveal emerging field risks.
1 market signals appeared in Germany during Week 16, 2026. Market signals help connect regulatory monitoring with launch planning, reimbursement, and commercial strategy.
These source-linked items support the weekly analysis above. They are included for verification and follow-up, not as a raw feed export.
LAI-PrEP testing strategies show similar HIV detection rates but RDTs offer faster results and lower costs.
SourcePhilips recalls ALLURA Xper FD20 OR Table due to intermittent X-ray imaging issues with the foot switch.
SourceMentor Texas, LP. recalls Class II Artoura Breast Tissue Expanders due to potential blunt needle tips.
SourceMedtronic MiniMed's Paradigm Insulin Pumps are recalled due to risks of insulin over- and under-delivery affecting patient safety.
SourceMentor Texas, LP. recalls Class II CPX 4 US Breast Tissue Expanders due to potential blunt needle tips.
SourcePhilips recalled Azurion 5 M12 due to intermittent X-ray imaging issues with the wired foot switch.
SourceSiemens recalls Atellica CH A1c_E due to potential negative bias affecting diabetes diagnosis.
SourceClass I recall issued for Automated Impella Controller due to alarm delay risk with first generation pumps.
SourceMedtronic's MiniMed 620G insulin pump recalled due to risks of insulin over- and under-delivery affecting patient safety.
SourceMentor Texas recalls Class II CPX 4 US Breast Tissue Expanders due to potential blunt needle tips.
SourceBD Kiestra ReadA (Catalog No. 446948) recalled due to intermittent remote connectivity issues post-reboot.
SourceMedtronic's Paradigm REAL-Time Veo Insulin Pump recalled due to insulin delivery errors causing severe health risks.
SourcePhilips recalls ALLURA Xper FD20 OR Table due to intermittent X-ray imaging issues with the foot switch.
SourceMentor Texas, LP. recalls Class II Artoura Breast Tissue Expanders due to potential blunt needle tips.
SourceMedtronic MiniMed's Paradigm Insulin Pumps are recalled due to risks of insulin over- and under-delivery affecting patient safety.
SourceMentor Texas, LP. recalls Class II CPX 4 US Breast Tissue Expanders due to potential blunt needle tips.
SourcePhilips recalled Azurion 5 M12 due to intermittent X-ray imaging issues with the wired foot switch.
SourceSiemens recalls Atellica CH A1c_E due to potential negative bias affecting diabetes diagnosis.
SourceClass I recall issued for Automated Impella Controller due to alarm delay risk with first generation pumps.
SourceMedtronic's MiniMed 620G insulin pump recalled due to risks of insulin over- and under-delivery affecting patient safety.
SourceLAI-PrEP testing strategies show similar HIV detection rates but RDTs offer faster results and lower costs.
SourceMedFlux monitors regulators and medical device market sources across priority countries so regulatory, quality, and strategy teams can review changes without manually checking agency databases.